StockTipsArenaBeta

BUY Colgate Palmolive (India) Limited — Sharekhan Research

BUYColgate Palmolive (India) Limited

bySharekhan ResearchHorizon: NA (inferred 1 year)27 May 2025via Institutional / Brokerage Research

Entry₹2,513.1Inferred
Target₹2,829
Total upside +12.57% (call closed)
Stop lossNot given
At expiry₹2,087.427 May 2026, 3:30 pm
Expired-16.94%
Follow Sharekhan Research for new calls(54% target hit, 510 closed calls)Get alertsWatch COLPAL for new buy/sell callsGet alertsSee 13 active Long-term calls on COLPALSee 90 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 9 Sept, 7:39 am IST
1 supporting2 neutral2 opposing
Supports the BUY call (1)

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·25 May · 2d ago

Neutral / worth noting (2)

Colgate Palmolive (India) Limited announced the approval of Audited Financial Results for the quarter and financial year ended March 31, 2026. The company also declared a second interim dividend of Rs

NSE · Press Release·22 May · 4d ago

(opens in new tab)

Colgate Palmolive (India) Limited announced its audited financial results for the fourth quarter and financial year ended March 31, 2026. The company also declared a second interim dividend of Rs. 24

NSE · Outcome of Board Meeting·22 May · 4d ago

(opens in new tab)
Weighs against the BUY call (2)

1 advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·25 May · 2d ago

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·24 Oct · 7mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.